31 Mar 2023
Assets666.23
Total Income443.26
EBITDA48.60
Profit After Tax-11.79
NET Worth384.73
Reserves and Surplus383.50
Total Borrowing196.21
At a glance
Updated 2026-08-24The shares listed at ₹490.00, a 6.52% move from the issue price. Nephrocare Health is a Mainboard IPO with an issue size of ₹871.05 crore, proposed for listing on BSE, NSE. The offer opens on 10th Dec 2025 and closes on 12th Dec 2025. The issue structure includes a fresh issue of ₹353.60 crore and an offer-for-sale component of ₹517.45 crore. The current listing schedule points to 17th Dec 2025.
Issue details
Listing atBSE, NSE
Issue typeBook Build Issue
Issue size₹871.05 Cr
Fresh issue₹353.60 Cr
Offer for sale₹517.45 Cr
Face value₹2
Price band₹438.00–₹460.00
Allotment15th Dec 2025
Listing17th Dec 2025
Listing performance
Full performance ↗Issue price₹460.00
Listing price₹490.00
Current price—
Listing gain6.52%
Current return—
Price progressionIssue → Listing → Current
Grey market
GMP page ↗Latest GMP₹40.00
GMP / upper price8.70%
Est. listing₹500.00
GMP is unofficial sentiment data, not an exchange price.
Timeline
Opens10th Dec 2025
Closes12th Dec 2025
Allotment15th Dec 2025
Refund16th Dec 2025
Demat16th Dec 2025
Listing17th Dec 2025
Subscription demand
Full bidding ↗Total14.08×
Lot size
| Investor | Lots | Shares | Amount |
|---|---|---|---|
| Minimum Bid | 1 | 32 | ₹14,720 |
Company
Incorporated2010
Use of proceeds
| Object | Amount |
|---|---|
| Capital expenditure by the Company for opening new dialysis clinics in India | ₹129.11 Cr |
| Pre-payment, or scheduled repayment, in full or part, of certain borrowings availed by the Company | ₹136.00 Cr |
| General Corporate Purposes | ₹60.05 Cr |
| Issue Expenses | ₹70.58 Cr |
| Total | ₹395.73 Cr |
Financials
Full financials ↗31 Mar 2024
Assets806.02
Total Income574.72
EBITDA99.66
Profit After Tax35.13
NET Worth423.55
Reserves and Surplus408.57
Total Borrowing243.37
31 Mar 2025
Assets996.46
Total Income769.92
EBITDA166.64
Profit After Tax67.10
NET Worth594.21
Reserves and Surplus578.68
Total Borrowing225.80
30 Sep 2025
Assets1,193.68
Total Income483.97
EBITDA110.31
Profit After Tax14.23
NET Worth716.06
Reserves and Surplus704.14
Total Borrowing207.04
Trend chart₹ crore
KPIs
| KPI | Mar 31, 2025 |
|---|---|
| ROE | 13.45% |
| ROCE | 18.67% |
| RoNW | 13.19% |
| PAT Margin | 8.88% |
| EBITDA Margin | 22.05% |
| Price to Book Value | 7.72 |
Valuation & shareholding
Pre-IPO EPS7.24
Post-IPO EPS2.84
Pre-IPO P/E63.52
Post-IPO P/E162.19
Promoter holding pre78.90%
Promoter holding post71.49%
Market cap₹4615.34 Cr.
Issue expenses
| Expense | Amount |
|---|---|
| Capital expenditure by the Company for opening new dialysis clinics in India | ₹129.11 Cr |
| Pre-payment, or scheduled repayment, in full or part, of certain borrowings availed by the Company | ₹136.00 Cr |
| General Corporate Purposes | ₹60.05 Cr |
| Issue Expenses | ₹70.58 Cr |
| Total | ₹395.73 Cr |
Registrar & lead managers
Registrar
Kfin Technologies Ltd.Lead managers
- ICICI Securities Ltd.
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-08-24.